Study of DP303c Injection in Patients With Advanced Ovarian Cancer

Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer

NCT04337632 ·Status: UNKNOWN ·Phase: PHASE3

Dendritic Cell Vaccination With Standard Postoperative Chemotherapy for the Treatment of Adult Ovarian Cancer

NCT05270720 ·Status: UNKNOWN ·Phase: PHASE1

Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian Cancer

NCT03858166 ·Status: TERMINATED ·Phase: PHASE4

Efficacy and Safety of Paclitaxel (Albumin-bound) Combination With Carboplatin in Ovarian Cancer.

NCT04661696 ·Status: UNKNOWN ·Phase: PHASE2

Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer

NCT04807166 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

The Culture of Advanced or Recurrent Ovarian Cancer Organoids and Drug Screening

NCT05290961 ·Status: UNKNOWN

A Phase III Study of BD0801 Combined With Chemotherapy in Recurrent, Platinum-resistant Epithelial Ovarian Cancer

NCT04908787 ·Status: COMPLETED ·Phase: PHASE3

Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer

NCT01253681 ·Status: COMPLETED ·Phase: PHASE1

Cytoreductive Surgery(CRS) Plus Hyperthermic Intraperitoneal Chemotherapy(HIPEC) With Lobaplatin in Advanced and Recurrent Epithelial Ovarian Cancer

NCT03371693 ·Status: UNKNOWN ·Phase: PHASE3

A Study of SHR-A1811 in Subjects With Ovarian Cancer

NCT06828354 ·Status: RECRUITING ·Phase: PHASE3

Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial

NCT01506856 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer

NCT00214058 ·Status: COMPLETED ·Phase: PHASE2

Evaluating the Efficacy of Hyperthermic Intraperitoneal Treatment to Enhance the Sensitivity of Immune Checkpoint Inhibitor in Patients With Advanced Ovarian Cancer： A Single-arm Study

NCT07068178 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Phase 3 Trial Evaluating Hyperthermic Intraperitoneal Chemotherapy in Upfront Treatment of Stage IIIC Epithelial Ovarian Cancer

NCT01628380 ·Status: UNKNOWN ·Phase: PHASE3

Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer

NCT00003386 ·Status: TERMINATED ·Phase: PHASE2

Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma

NCT00758732 ·Status: TERMINATED ·Phase: PHASE2

Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian Cancer

NCT07125391 ·Status: RECRUITING ·Phase: PHASE2

Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer

NCT05737303 ·Status: RECRUITING ·Phase: PHASE3

Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT00003560 ·Status: UNKNOWN ·Phase: PHASE2

An Exploratory Study on NK Cell-assisted Prevention of Bone Marrow Suppression During Chemotherapy for Ovarian Cancer

NCT07096583 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Efficacy of HIPEC in the Treatment of Advanced-Stage Epithelial Ovarian Cancer After Cytoreductive Surgery

NCT03373058 ·Status: UNKNOWN ·Phase: PHASE3

Efficacy and Safety of SG001 Combined With PLD in Patients With Platinum-resistant Relapsed EOC

NCT04983550 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer

NCT07030907 ·Status: RECRUITING ·Phase: PHASE1

PD-1 Antibody Combined Neoadjuvant Chemotherapy for Ovarian Cancer

NCT04815408 ·Status: UNKNOWN ·Phase: PHASE2

Dose-dense Chemotherapy Versus Intraperitoneal Chemotherapy as First-line Chemotherapy in Advanced Ovarian Cancer

NCT04135521 ·Status: COMPLETED